Pharming Group N.V. (PHAR)

Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.09	54.94	61.74	207.34	191.92	205.16
Short-Term Investments	47.18	112.95	151.68	-	-	-
Cash & Short-Term Investments	107.27	167.89	213.42	207.34	191.92	205.16
Cash Growth	-46.89%	-21.33%	2.93%	8.03%	-6.45%	175.94%
Accounts Receivable	47.49	41.53	35.41	20.96	18.08	23.51
Other Receivables	-	8.64	7.21	4.37	9.52	8.37
Receivables	47.49	50.17	42.62	25.33	27.59	31.88
Inventory	59.35	55.72	56.76	42.33	27.31	21.16
Prepaid Expenses	-	4.65	3.54	2.29	2.39	4.02
Restricted Cash	-	-	-	0.21	0.23	1
Total Current Assets	214.11	278.44	316.34	277.5	249.44	263.21
Property, Plant & Equipment	24.23	24.13	33.47	39.15	33.17	21.65
Long-Term Investments	5.92	4.23	10.4	9.73	8.65	7.12
Other Intangible Assets	138.86	61.04	71.27	74.87	83.57	88.63
Long-Term Deferred Tax Assets	18.39	30.54	29.76	22.97	21.22	31.88
Long-Term Deferred Charges	-	-	-	0.25	0.27	5.46
Other Long-Term Assets	1.67	1.6	1.62	1.33	1.01	0.51
Total Assets	403.18	399.99	462.85	425.8	397.32	418.45
Accounts Payable	68.75	10.1	16.02	8.75	7.6	13.47
Accrued Expenses	-	53.22	50.27	43.61	33.34	33.4
Current Portion of Long-Term Debt	4.56	4.25	1.82	1.77	1.88	2.04
Current Portion of Leases	4.23	2.95	3.62	3.47	2.42	1.96
Current Income Taxes Payable	-	3.28	6.23	2.1	1.51	0.62
Other Current Liabilities	-	-	-	-	0.03	25.36
Total Current Liabilities	77.54	73.8	77.97	59.7	46.77	76.85
Long-Term Debt	83.85	78.15	136.6	131.62	139.01	149.73
Long-Term Leases	26.51	26.97	29.51	29.84	18.46	8.23
Other Long-Term Liabilities	-	-	-	-	0.17	0.21
Total Liabilities	187.89	178.92	244.07	221.16	204.4	235.02
Common Stock	7.81	7.77	7.67	7.51	7.43	7.31
Additional Paid-In Capital	490.3	488.99	478.43	462.3	455.25	447.13
Retained Earnings	-284.11	-287.92	-265.5	-265.17	-269.77	-271.01
Comprehensive Income & Other	-	12.23	-1.82	-	-	-
Shareholders' Equity	215.29	221.06	218.78	204.64	192.92	183.44
Total Liabilities & Equity	403.18	399.99	462.85	425.8	397.32	418.45
Total Debt	119.14	112.31	171.55	166.69	161.76	161.96
Net Cash (Debt)	-11.87	55.58	41.88	40.65	30.16	43.2
Net Cash Growth	-	32.72%	3.03%	34.76%	-30.18%	167.52%
Net Cash Per Share	-0.02	0.08	0.06	0.06	0.04	0.06
Filing Date Shares Outstanding	669.05	683.93	673.44	656.35	648.75	641.29
Total Common Shares Outstanding	669.05	680.31	671.07	656.35	648.75	638.82
Working Capital	136.57	204.64	238.37	217.8	202.67	186.36
Book Value Per Share	0.32	0.32	0.33	0.31	0.30	0.29
Tangible Book Value	75.14	160.02	147.51	129.77	109.35	94.81
Tangible Book Value Per Share	0.11	0.24	0.22	0.20	0.17	0.15
Land	-	-	-	-	0.03	0.03
Machinery	-	9.3	9.66	8.28	14.84	6.59
Construction In Progress	-	0.15	0.18	0.01	0.62	2.87
Leasehold Improvements	-	5.43	5.55	5.28	5.71	2.48

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q